|
Real-time
Euronext Bruxelles
01:13:52 24/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 221.50 EUR | -0.09% |
|
+2.88% | -7.12% |
| 20/08 | Cancer vaccines finally garner the spotlight |  |
| 19/08 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.93TCr | |||||
| 8.33TCr | |||||
| 5.79TCr | - | ||||
| 5.78TCr | |||||
| 5.17TCr | |||||
| 3.2TCr |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
